Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working GroupMohamed Amgad, Shom Goel, Elisabeth Specht Stovgaard et al.|npj Breast Cancer|2020Cited by 168
Array CGH and DNA sequencing to personalize targeted treatment of metastatic breast cancer (MBC) patients (pts): A prospective multicentric trial (SAFIR01).Fabrice André, Hervé Bonnefoi, Thomas Bachelot et al.|Journal of Clinical Oncology|2013Cited by 20
Low risk of invasive lobular carcinoma of the breast in carriers of <i>BRCA1</i> (hereditary breast and ovarian cancer) and <i>TP53</i> (Li‐Fraumeni syndrome) germline mutationsYoan Ditchi, Patrick R. Benusiglio, Donia Lejri et al.|The Breast Journal|2018Cited by 16